PhD course in Molecular, Experimental and Computational Medicine (MECM)

Position: Doctorate Institute: Humanitas Uni.
Posted on: 27/05/2026 Deadline: 26/06/2026

Scientific-Disciplinary Group

05/BIOS-07 - Biochemistry, 05/BIOS-10 - Cellular And Experimental Biology, 05/BIOS-11 - Pharmacology, 05/BIOS-12 - Human Anatomy, 05/BIOS-13 - Human Histology And Embryology, 05/BIOS-14 - Genetics, 06/MEDS-01 - Medical Genetics, 06/MEDS-02 - Experimental Medicine, Pathophysiology And Clinical Pathology, 06/MEDS-04 - Pathology, 06/MEDS-06 - General Surgery, 06/MEDS-07 - Cardiovascular And Respiratory Diseases, 06/MEDS-09 - Blood Diseases, Oncology And Rheumatology, 06/MEDS-10 - Gastrointestinal, Infectious And Skin Diseases, 06/MEDS-12 - Neurology, 06/MEDS-19 - Orthopaedics And Rehabilitation Medicine, 06/MEDS-22 - Imaging, Radiotherapy And Neuroradiology

Description

The main objective of the PhD programme in MECM – Molecular, Experimental and Computational Medicine, developed in collaboration with IRCCS Humanitas Research Hospital, is to provide researchers and physicians with a strong foundational, methodological, and experimental training, preparing them to address scientific and clinical challenges in the complex and innovative fields of molecular medicine. The training is developed across transversal and multidisciplinary research areas, including oncology, immunology, cardiovascular, neurodegenerative, and metabolic sciences, with a particular focus on advanced cellular and molecular analysis techniques and personalized medicine.

Number of positions

8

Funding body

HUMANITAS UNIVERSITY

Selection process

Click to expand
Admission to the PhD Programme is based on a public selection process consisting of the comparative evaluation of the titles and qualifications of the applicants and of an interview